ARTICLE | Financial News
Synergy raises $175M in note deal
October 30, 2014 2:26 AM UTC
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) raised $175 million through the sale of senior unsecured convertible notes. The notes bear 7.5% interest, mature in 2019 and initially convert at $3.11.
Synergy's lead compound is plecanatide, a guanylate cyclase C ( GCC; GUCY2C) agonist that is in two Phase III trials for chronic idiopathic constipation. ...